Investment

Reliance Industries Ltd. has strengthened its international consumer portfolio by acquiring a stake in an Australian beverage business, underscoring its ambition to scale globally in fast-moving consumer goods. The investment reflects Reliance’s strategy of targeting high-growth categories such as premium beverages, where demand is driven by evolving consumer preferences and brand-led differentiation. While financial details of the transaction were not disclosed, the move positions Reliance to leverage Australia’s mature beverage market and export-oriented ecosystem.

Bollywood actor Ishaan Khatter has expanded his personal asset portfolio with the acquisition of a residential apartment in Mumbai’s upscale Pali Hill locality, according to people familiar with the transaction. The purchase underscores a growing trend among young film industry professionals who are channeling earnings into high-value real estate as a long-term investment strategy. Pali Hill, known for its exclusivity and proximity to the entertainment industry, remains one of the city’s most sought-after residential addresses.

Sun Pharmaceutical Industries Ltd is investing Rs 500 crore to establish a new state-of-the-art manufacturing plant in Assam, underscoring its commitment to expanding production capacity and strengthening its presence in India’s northeast. The facility will focus on high-demand formulations, enhancing supply chain efficiency and catering to domestic and international markets. This strategic investment aligns with Sun Pharma’s broader growth agenda of optimizing operational capabilities while leveraging regional advantages.

Tube Investments of India Ltd. delivered a stable financial performance in the third quarter, reporting a profit after tax of Rs. 279 crore, reflecting resilience across its diversified business portfolio. The performance was supported by steady demand in core manufacturing segments, operational efficiencies, and disciplined capital deployment. While macroeconomic uncertainty and cost pressures persisted, the company managed to protect profitability through prudent execution and portfolio diversification.

Global private equity major Advent International has committed Rs. 2,750 crore to Aditya Birla Housing Finance Ltd., underscoring growing investor confidence in India’s expanding housing finance market. The capital infusion is aimed at strengthening the lender’s balance sheet, accelerating loan growth and enhancing digital and distribution capabilities. The deal reflects a broader trend of global funds increasing exposure to India’s financial services sector, driven by favorable demographics, urbanization and policy support for home ownership.

JS Auto Cast, a leading automotive components manufacturer, has secured a strategic investment of Rs. 300 crore from Premji Invest, signaling strong investor confidence in its growth trajectory and operational capabilities. The infusion of capital is expected to strengthen the company’s balance sheet, fund capacity expansion, and support technological upgrades aimed at enhancing production efficiency.

The Union government is considering a Rs. 10,000 crore investment proposal for the biopharmaceutical sector in the forthcoming budget, signaling a strategic shift toward innovation-led healthcare growth. The planned allocation aims to strengthen research and development, expand advanced manufacturing capabilities, and reduce reliance on imported biologics and critical inputs. The move reflects lessons drawn from recent global health disruptions and aligns with India’s ambition to emerge as a global biopharma and life sciences hub.

The State Bank of India (SBI) Chairman has called for taxation parity between bank deposits and equity investments, highlighting a structural imbalance that discourages long-term investment in equities. Speaking at a financial forum, he emphasized that disproportionate taxation on fixed deposits compared to capital gains from equities has created suboptimal investment behavior, leading to lower market participation and savings inefficiency.

Cholamandalam Investment and Finance Company Ltd. (CIFCL) recorded a Gross Written Premium (GWP) of Rs 2,337 crore for the third quarter, signaling a steady performance in India’s competitive insurance sector. The company’s growth reflects robust retail and commercial penetration, underpinned by diversified product offerings and strategic distribution channels. Analysts note that the figure highlights the resilience of non-life insurance demand, supported by rising awareness and regulatory impetus.

Paytm’s core business continues to demonstrate resilience, prompting Jefferies to reaffirm its “Buy” rating on the Indian fintech giant. The company’s robust digital payments ecosystem, expanding merchant base, and sustained user engagement have underpinned steady revenue growth, despite broader macroeconomic pressures. Analysts note that Paytm’s focus on financial services, including credit, insurance, and wealth management, positions it well for long-term profitability.